Regeneron Pharmaceuticals, Inc.
2013 Q4 - 2025 Q4 (28 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/3/2026 | 10,850 | 0.1% | 14,057 | 12/31/2025 |
| 2025 Q3 | 10/24/2025 | 8,007 | 0.1% | 14,241 | 9/30/2025 |
| 2025 Q2 | 7/10/2025 | 7,490 | 0.1% | 14,266 | 6/30/2025 |
| 2025 Q1 | 4/28/2025 | 10,998 | 0.1% | 17,341 | 3/31/2025 |
| 2024 Q4 | 1/28/2025 | 14,155 | 0.1% | 19,872 | 12/31/2024 |
| 2024 Q3 | 10/17/2024 | 20,205 | 0.2% | 19,220 | 9/30/2024 |
| 2024 Q2 | 7/30/2024 | 14,541 | 0.2% | 13,835 | 6/30/2024 |
| 2024 Q1 | 5/2/2024 | 12,770 | 0.2% | 13,268 | 3/31/2024 |
| 2023 Q4 | 2/1/2024 | 11,252 | 0.1% | 12,811 | 12/31/2023 |
| 2023 Q3 | 10/30/2023 | 9,913 | 0.2% | 12,045 | 9/30/2023 |
| 2023 Q2 | 8/4/2023 | 8,876 | 0.1% | 12,353 | 6/30/2023 |
| 2023 Q1 | 5/2/2023 | 8,063 | 0.1% | 9,813 | 3/31/2023 |
| 2022 Q4 | 1/26/2023 | 6,861 | 0.1% | 9,509 | 12/31/2022 |
| 2022 Q3 | 10/19/2022 | 6,553 | 0.1% | 9,512 | 9/30/2022 |
| 2022 Q2 | 7/13/2022 | 5,408 | 0.1% | 9,149 | 6/30/2022 |
| 2022 Q1 | 4/19/2022 | 6,405 | 0.1% | 9,171 | 3/31/2022 |
| 2021 Q4 | 1/20/2022 | 5,328 | 0.1% | 8,437 | 12/31/2021 |
| 2021 Q3 | 10/15/2021 | 4,886 | 0.1% | 8,074 | 9/30/2021 |
| 2021 Q2 | 7/19/2021 | 4,526 | 0.1% | 8,104 | 6/30/2021 |
| 2021 Q1 | 5/7/2021 | 3,833 | 0.1% | 8,103 | 3/31/2021 |
| 2020 Q4 | 2/2/2021 | 3,786 | 0.1% | 7,838 | 12/31/2020 |
| 2020 Q3 | 10/29/2020 | 4,219 | 0.1% | 7,538 | 9/30/2020 |
| 2020 Q2 | 8/12/2020 | 4,456 | 0.2% | 7,146 | 6/30/2020 |
| 2020 Q1 | 4/21/2020 | 2,469 | 0.1% | 5,058 | 3/31/2020 |
| 2019 Q4 | 1/24/2020 | 1,869 | 0.1% | 4,979 | 12/31/2019 |
| 2014 Q2 | 7/14/2014 | 2,263 | 0.1% | 8,013 | 6/30/2014 |
| 2014 Q1 | 4/16/2014 | 2,497 | 0.1% | 8,316 | 3/31/2014 |
| 2013 Q4 | 1/22/2014 | 2,346 | 0.1% | 8,526 | 12/31/2013 |